HHS Secretary Robert F. Kennedy Jr. paused a Biden-era contract with Vaxart Inc. to create a new COVID-19 vaccine, part of the $4.7 billion Project NextGen initiative. The trial is paused for 90 days with a stop-work order issued. Kennedy aims to ensure the vaccine technology is safe, effective, and fiscally responsible.
Key Points
HHS Secretary Robert F. Kennedy Jr. paused a contract with Vaxart Inc. for a new COVID-19 vaccine
The trial is paused for 90 days with a stop-work order issued
The contract is part of the Biden administration's Project NextGen initiative
Pros
Ensures review of vaccine production agreements for safety and effectiveness
Aims to streamline the development of new vaccines
Cons
Pause may delay progress in COVID-19 vaccine development